Exam 9: Share-Based Payments
Exam 1: Accounting Regulation and the Conceptual Framework29 Questions
Exam 2: Application of Accounting Theory30 Questions
Exam 4: Fair Value Measurement29 Questions
Exam 5: Revenue30 Questions
Exam 6: Provisions, Contingent Liabilities and Contingent Assets30 Questions
Exam 7: Income Taxes22 Questions
Exam 8: Financial Instruments29 Questions
Exam 10: Translation of the Financial Statements of Foreign Entities19 Questions
Exam 11: Employee Benefits30 Questions
Exam 12: Inventories29 Questions
Exam 13: Property, Plant and Equipment27 Questions
Exam 14: Leases24 Questions
Exam 15: Understanding Australian Accounting Standards24 Questions
Exam 16: Impairment of Assets23 Questions
Exam 17: Accounting for Mineral Resources30 Questions
Exam 18: Agriculture30 Questions
Exam 19: Financial Statement Presentation30 Questions
Exam 20: Statement of Cash Flows30 Questions
Exam 22: Operating Segments30 Questions
Exam 23: Operating Segments30 Questions
Exam 24: Business Combinations23 Questions
Exam 25: Consolidation: Principles and Accounting Requirements30 Questions
Exam 26: Consolidation: Intragroup Transactions30 Questions
Exam 27: Consolidation: Non Controlling Interest30 Questions
Exam 29: Joint Arrangements25 Questions
Exam 30: Associates and Joint Ventures26 Questions
Select questions type
THE FOLLOWING INFORMATION RELATES TO QUESTIONS
Viola Ltd has granted each of its 10 senior executives a choice between receiving a cash payment equivalent to 1000 shares or receiving 1200 share. The grant is conditional on the completion of three years service with the company. If the share alternative is chosen, the shares must be held for two years after vesting date. At grant date the company’s share price is $25 per share. At the end of years 1, 2 and 3 the share price is $27, $28 and $30 respectively. The company does not expect to pay dividends in the next three years. After taking into account the effect of post-vesting transfer restrictions the company estimates the grant-date fair value of the share alternative is $24 per share.
-What is the liability component at the end of year 1?
Free
(Multiple Choice)
4.7/5
(37)
Correct Answer:
B
On 1 July 2013, Nelson Pty Ltd granted 250 options to each of its 50 employees. The options are conditional on the employees remaining with the company for the 3 year vesting period. The options have a fair value of $7.50 at vesting date. In addition, the shares will vest as follows:
• On 30 June 2014 if the company’s earnings have increased by more than 12%
• On 30 June 2015 if the company’s earnings have increased by more than 10% averaged across the 2 year period
• On 30 June 2016 if the company’s earnings have increased by more than 8% averaged across the 3 year period
At 30 June 2014 Nelson's earnings have increased by 11% and 3 employees have left.
The company expects that earnings will continue to increase at a similar rate during the year to 30 June 2015 and that the shares will vest at that time. It also expects that a further 4 employees will leave during the year.
The remuneration expense for the year ended 30 June 2014 for Nelson is:
Free
(Multiple Choice)
4.9/5
(32)
Correct Answer:
C
Pepper Limited grants 500 share options to each of its 30 employees. Each grant is conditional on the employee working for the company for the next three years. The fair value of each option is estimated to be $5.00 at grant date and $7.50 at vesting date.
The amount to be recognised as an expense by Pepper in year 2 is:
Free
(Multiple Choice)
4.9/5
(41)
Correct Answer:
A
On 1 July 2013 Pearl Pty Ltd granted 800 share options with an exercise price of $35 to the CFO, conditional on the CFO remaining in employment with the company until 30 June 2016. The fair value of Pearl's shares at that time were assessed to be $40. The exercise price will drop to $30 if Pearl's earnings increase by an average of 8% per year over the three year period. On 1 July 2013 the estimated fair value of the share options with an exercise price of $35 is $10 per option, and if the exercise price is $30, the estimated fair value of the options is $12 per option.
During the year ended 30 June 2014 Pearl's earnings increased by 10% and they are expected to continue to increase at this rate over the next two years.
During the year ended 30 June 2015 Pearl's earnings increased by 9% and Pearl management continued to expect that the earnings target would be achieved.
During the year ended 30 June 2016 Pearl's earnings increased by only 2%. At 30 June 2016 the share price is $23.
Assuming that the CFO decides NOT to exercise his options at 30 June 2016, the following entry would be recorded:
(Multiple Choice)
4.8/5
(38)
Which of the following is NOT within the scope of AASB 2 Share-based Payment.
(Multiple Choice)
5.0/5
(36)
On 1 July 2013, Leo Limited granted 250 options to each of its 50 employees. The options are conditional on the employees remaining with the company for the 2 year vesting period. The options have a fair value of $10 at vesting date. In addition, the shares will vest as follows:
On 30 June 2014 if the company's earnings have increased by more than 15%
On 30 June 2015 if the company's earnings have increased by more than 12% averaged across the 2 year period
At 30 June 2014 Leo's earnings have increased by 12% and 3 employees have left.
The company expects that earnings will continue to increase at a similar rate during the year to 30 June 2015 and that the shares will vest at that time. It also expects that a further 4 employees will leave during the year.
The remuneration expense for the year ended 30 June 2014 for Leo is:
(Multiple Choice)
4.9/5
(28)
A share-based payment transaction in which the entity receives goods or services as consideration for equity instruments of the entity is classified in AASB 2 Share-based Payment as
(Multiple Choice)
4.7/5
(35)
THE FOLLOWING INFORMATION RELATES TO QUESTIONS
On 1 July 2013 Watson Pty Ltd granted 100 share appreciation rights (SARS) to each of its 50 employees, conditional on the employee not leaving the company in the next three years. The company estimates the fair value of the SARS at the end of each year in which a liability exists as shown in the table below. The intrinsic values of the SARS at the date of exercise at 30 June 2016, 2017 and 2018 are also shown. All SARS held by employees at 30 June 2016 vest.
Year ended Fair value Intrinsic value 30 June 2014 \ 14.40 30 June 2015 \ 15.50 30 June 2016 \ 18.20 \ 15.00 30 June 2017 \ 21.40 \ 20.00 30 June 2018 \ 25.00
By 30 June 2016 nine employees have left and 15 employees have exercised their SARS.
-The amount recognised as an expense for the year ended 30 June 2016 is:
(Multiple Choice)
4.9/5
(36)
A share-based payment transaction in which the entity receives goods or services as consideration for equity instruments of the entity is classified in AASB 2 Share-based Payment as
(Multiple Choice)
4.8/5
(39)
THE FOLLOWING INFORMATION RELATES TO QUESTIONS
On 1 July 2013 Watson Pty Ltd granted 100 share appreciation rights (SARS) to each of its 50 employees, conditional on the employee not leaving the company in the next three years. The company estimates the fair value of the SARS at the end of each year in which a liability exists as shown in the table below. The intrinsic values of the SARS at the date of exercise at 30 June 2016, 2017 and 2018 are also shown. All SARS held by employees at 30 June 2016 vest.
Year ended Fair value Intrinsic value 30 June 2014 \ 14.40 30 June 2015 \ 15.50 30 June 2016 \ 18.20 \ 15.00 30 June 2017 \ 21.40 \ 20.00 30 June 2018 \ 25.00
By 30 June 2016 nine employees have left and 15 employees have exercised their SARS.
-The liability recorded at 30 June 2015 is:
(Multiple Choice)
4.8/5
(32)
THE FOLLOWING INFORMATION RELATES TO QUESTIONS
Viola Ltd has granted each of its 10 senior executives a choice between receiving a cash payment equivalent to 1000 shares or receiving 1200 share. The grant is conditional on the completion of three years service with the company. If the share alternative is chosen, the shares must be held for two years after vesting date. At grant date the company’s share price is $25 per share. At the end of years 1, 2 and 3 the share price is $27, $28 and $30 respectively. The company does not expect to pay dividends in the next three years. After taking into account the effect of post-vesting transfer restrictions the company estimates the grant-date fair value of the share alternative is $24 per share.
-What is the fair value of the cash alternative?
(Multiple Choice)
4.8/5
(33)
Which of the following statements in relation to modifications to the terms and conditions on which equity instruments were granted as part of an employee share scheme is correct?
(Multiple Choice)
4.9/5
(41)
In situations where an option-pricing model is required to be used to determine the fair value of equity instruments granted AASB 2 Share-based Payment:
(Multiple Choice)
4.8/5
(29)
Which of the following statements in relation to disclosures required under AASB 2 Share-based Payment is not correct?
(Multiple Choice)
4.8/5
(40)
Which of the following is within the scope of AASB 2 Share-based Payment.
(Multiple Choice)
4.9/5
(21)
On 1 July 2013 Pearl Pty Ltd granted 800 share options with an exercise price of $35 to the CFO, conditional on the CFO remaining in employment with the company until 30 June 2016. The fair value of Pearl's shares at that time were assessed to be $40. The exercise price will drop to $30 if Pearl's earnings increase by an average of 8% per year over the three year period. On 1 July 2013 the estimated fair value of the share options with an exercise price of $35 is $10 per option, and if the exercise price is $30, the estimated fair value of the options is $12 per option.
During the year ended 30 June 2014 Pearl's earnings increased by 10% and they are expected to continue to increase at this rate over the next two years.
During the year ended 30 June 2015 Pearl's earnings increased by 9% and Pearl management continued to expect that the earnings target would be achieved.
During the year ended 30 June 2016 Pearl's earnings increased by only 2%. At 30 June 2016 the share price is $23.
The remuneration expense to be recognised for the year ended 30 June 2014 is:
(Multiple Choice)
4.8/5
(38)
In relation to equity instruments granted by an entity where the entity makes modifications to the terms and conditions attaching to the grant:
(Multiple Choice)
4.8/5
(43)
On 1 July 2013 Diamond Ltd granted 800 share options with an exercise price of $35 to the CFO, conditional on the CFO remaining in employment with the company until 30 June 2016. The exercise price will drop to $30 if Diamond's earnings increase by an average of 8% per year over the three year period. On 1 July 2013 the estimated fair value of the share options with an exercise price of $35 is $10 per option, and if the exercise price is $30, the estimated fair value of the options is $12 per option.
During the year ended 30 June 2014 Diamond's earnings increased by 10% and they are expected to continue to increase at this rate over the next two years.
During the year ended 30 June 2015 Diamond's earnings increased by 5% and Diamond management expected that the earnings target would be achieved.
During the year ended 30 June 2016 Diamond's earnings increased by 11%.
When calculating the remuneration expense to be recognised for the year ended 30 June 2015 which of the following dollar values should be included in the calculation?
(Multiple Choice)
4.7/5
(42)
In a share based payment transaction where the entity has settlement choice:
(Multiple Choice)
4.8/5
(27)
Showing 1 - 20 of 30
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)